European Market for Hip, Knee Replacements

An aging population and technologic advances are projected to boost the hip and knee replacement market in Europe from an estimated U.S.$1.40 billion in 2004 to $1.83 billion in 2010, according to a new report from Frost & Sullivan (Palo Alto, CA, USA), international growth consultants.

Continued pressure to reduce the number of people waiting for joint replacement surgery has been paralleled by a shift in total knee and hip replacement procedures from major replacement centers to general acute hospitals. This has reduced waiting times, augmented the number of procedures performed, and stimulated market growth.

Novel manufacturing techniques and new materials technology such as bone substitutes, bioabsorbable products, specialized alloys, and innovative joint-replacement product designs are all contributing to overall market value. Medical robotics, computer-assisted surgery, minimally invasive joint-replacement surgery, and bio-engineered technologies are projected to influence the development of innovative new products.

"The challenge to industry is to overcome some of the natural prejudices that the surgeons may have concerning robotics and computer assistance during surgery and ensure that implant technologies complement the use of computers during surgery,” cautioned Tanya Pullen, industry manager at Frost & Sullivan.

The competitive landscape has been shaped by a series of major acquisitions, mergers, and joint ventures. These changes have led to a streamlining of operational logistics, including the restructuring of manufacturing, sales, and marketing activities together with a rationalization of the product portfolio and product group responsibilities.

"In addition, the market has seen a slow but deliberate emphasis away from the use of local distributors, a consolidation of related orthopedic products and service activities, and a greater emphasis on supplying the market directly through subsidiaries,” noted Ms. Pullen.




Related Links:
Frost & Sullivan